Overview

Cipralex® for Anxiety Disorders in Adolescents

Status:
Unknown status
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The primary objective is to examine whether Cipralex® is effective and safe in the treatment of anxiety disorders in youth. The secondary objective is to identify changes in arousal and stress response from pre- to post-treatment with Cipralex® in youth with anxiety disorders.
Phase:
Phase 1
Details
Lead Sponsor:
University of Ottawa
Collaborator:
H. Lundbeck A/S
Treatments:
Citalopram
Dexetimide